Side-by-Side Comparison · 2026

AOD-9604 vs Dulaglutide

AOD-9604 vs Dulaglutide — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?

AOD-9604
Metabolic & Mitochondrial

AOD-9604 (Anti-Obesity Drug 9604) is a synthetic fragment of human growth hormone (hGH), specifically the C-terminal region spanning amino acids 176-191 with an additional tyrosine at position 177. It was designed to isolate the fat-metabolizing properties of hGH without the IGF-...

Calculate AOD-9604 dose →
Dulaglutide
Metabolic & Mitochondrial

Dulaglutide (Trulicity) is a once-weekly GLP-1 receptor agonist approved by the FDA for the treatment of type 2 diabetes and for reducing cardiovascular events in adults with T2DM or cardiovascular risk factors. It is an Fc-fusion protein consisting of two modified GLP-1 molecule...

Calculate Dulaglutide dose →
Key Parameters
Parameter AOD-9604 Dulaglutide
Category Metabolic & Mitochondrial Metabolic & Mitochondrial
Research Phase IIb (Discontinued) FDA Approved
Half-Life ~30 minutes ~5 days
Typical Dose 300 µg 0.75–4.5 mg
Frequency Once daily (fasted) Once weekly
Route Subcutaneous / Oral Subcutaneous (weekly)
FDA Status Not Approved Approved

Calculate doses for both

Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.

Frequently Asked Questions
What is the difference between AOD-9604 and Dulaglutide?
AOD-9604: AOD-9604 (Anti-Obesity Drug 9604) is a synthetic fragment of human growth hormone (hGH), specifically the C-terminal region spanning amino acids 176-191 with an additional tyrosine at position 177. It... Dulaglutide: Dulaglutide (Trulicity) is a once-weekly GLP-1 receptor agonist approved by the FDA for the treatment of type 2 diabetes and for reducing cardiovascular events in adults with T2DM or cardiovascular ri...
Which has a longer half-life, AOD-9604 or Dulaglutide?
AOD-9604 half-life: ~30 minutes. Dulaglutide half-life: ~5 days.
Can you stack AOD-9604 and Dulaglutide?
AOD-9604 and Dulaglutide are in the same category and used together in research protocols. Always consult relevant literature and follow appropriate guidelines.

For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.